Phase II Pharmacokinetics Study of CAM2038

Clinical trial NCT02710526 · COMPLETED

Trial details

NCT number: NCT02710526
Sponsor: Braeburn Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Opioid Use Disorder Chronic Pain

Start date: 2015-02-01
Primary completion: 2017-05-17
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.